Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

FXR

The bile acid receptor (BAR), also known as farnesoid X receptor (FXR) or NR1H4 (nuclear receptor subfamily 1, group H, member 4) is a nuclear receptor that is encoded by the NR1H4 gene in humans.FXR is expressed at high levels in the liver and intestine. Chenodeoxycholic acid and other bile acids are natural ligands for FXR. Similar to other nuclear receptors, when activated, FXR translocates to the cell nucleus, forms a dimer (in this case a heterodimer with RXR) and binds to hormone response elements on DNA, which up- or down-regulates the expression of certain genes.

  • Forskolin
    T293966575-29-9
    Forskolin (Coleonol) is a natural product, an adenylate cyclase activator (EC50=0.5 μM). Forskolin increases cAMP levels, activates PXR and FXR, and induces autophagy. Forskolin produces positive inotropic effects in the heart, and has platelet anticoagulant and antihypertensive effects.
    • $36
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    TargetMol | Citations Cited
  • Obeticholic Acid
    T1789459789-99-2
    Obeticholic Acid (6-ECDCA) is a Farnesoid X Receptor Agonist. The mechanism of action of obeticholic acid is as a Farnesoid X Receptor Agonist.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
  • Lithocholic acid
    T2202434-13-9
    Lithocholic acid (3α-Hydroxy-5β-cholanic acid) is a bile acid formed from chenodeoxycholate by bacterial action, usually conjugated with glycine or taurine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. It is used as cholagogue and choleretic.
    • $46
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Androsterone
    T526453-41-8
    Androsterone, a metabolic product of testosterone, can activate Farnesoid X Receptor (FXR).
    • $46
    In Stock
    Size
    QTY
  • GSK2324
    T274601020567-30-9In house
    GSK2324 is a potent FXR agonist for the treatment of NAFLD by controlling hepatic lipids through reduced uptake and selective reduction of fatty acid synthesis.
    • $342
    In Stock
    Size
    QTY
  • Altenusin
    T889531186-12-6In house
    Altenusin is a natural nonsteroidal fungal metabolite, as a novel selective agonist of FXR with an EC50 value of 3.2 ± 0.2 μM.
    • $389
    In Stock
    Size
    QTY
  • Ursodeoxycholic acid sodium
    T290782898-95-5In house
    Ursodeoxycholic acid sodium (Sodium Ursodeoxycholate) is a naturally occurring secondary bile acid with anti-inflammatory and cytoprotective activities. Ursodeoxycholic acid sodium acts as signaling molecule, exerting its effects by interacting with bile acid activated receptors,
    • $118
    In Stock
    Size
    QTY
  • T0901317
    T6690293754-55-9
    T0901317 is a potent and selective agonist for both LXR and FXR, with EC50 of ~50 nM and 5 μM, respectively; it inhibits nuclear factor/κB (NF/κB).
    • $32
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • GW 4064
    T2233278779-30-9
    GW 4064 is an effective farnesoid X receptor (FXR) agonist (EC50 =65 nM).
    • $46
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Fexaramine
    T2015574013-66-4
    Fexaramine is a small molecule farnesoid X receptor (FXR) agonist with 100-fold increased affinity compared to natural compounds.
    • $42
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Hyodeoxycholic acid
    T296883-49-8
    Hyodeoxycholic acid (NSC 60672) has been used in trials studying the treatment of Hypercholesterolemia.
    • $38
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Turofexorate Isopropyl
    T6053629664-81-9
    Turofexorate Isopropyl (XL335) is a potent, selective, and orally bioavailable FXR agonist with EC50 of 4 nM
    • $39
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Chenodeoxycholic acid
    T0847474-25-9
    Chenodeoxycholic acid (CDCA) is a bile acid, usually conjugated with either glycine or taurine. It acts as a detergent to solubilize fats for intestinal absorption and is reabsorbed by the small intestine. It is used as cholagogue, a choleretic laxative, and to prevent or dissolve gallstones.
    • $55
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • ZLY28
    T78910
    ZLY28 is a novel, first-in-class compound with specific intestinal restriction and oral activity, serving as a dual modulator of FXR and FABP1. Additionally, it is a pioneering anti-NASH agent, utilized in the study of nonalcoholic steatohepatitis (NASH) [1].
    • $353
    35 days
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Tauro-β-muricholic acid sodium
    T13093145022-92-0
    Tauro-β-muricholic Acid sodium is a endogenous metabolite, is a competitive and reversible antagonist of farnesoid X receptor (FXR)(IC50 of 40 μM).
    • $180
    35 days
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Sevelamer hydrochloride
    T6344152751-57-0
    Sevelamer hydrochloride (Sevelamer HCl) is a phosphate binding drug used to treat hyperphosphatemia via binding to dietary phosphate and prevents its absorption.
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Tauro-β-muricholic acid
    T8103025696-60-0
    Tauro-β-muricholic acid (TβMCA), a trihydroxylated bile acid, acts as a competitive and reversible FXR antagonist (IC 50 = 40 μM) and exhibits antiapoptotic effects by inhibiting bile acid-induced hepatocellular apoptosis and preserving mitochondrial membrane potential [1] [2].
    • Inquiry Price
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Chenodeoxycholic Acid sodium salt
    T650702646-38-0
    Chenodeoxycholic Acid sodium salt (CDCA sodium salt) is a bile acid in humans that activates the nuclear receptor FXR, rescues axonal degeneration of induced pluripotent stem cell-derived neurons in patients with spastic paraplegia type 5 and cerebral xanthomatosis, and can be used to study pancreatic necrosis.
    • $31
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • Osocimab
    T771242056878-75-0
    Osocimab (BAY 1213790) is a potent anti-FXIa antibody with a Ki value of 2.4 nM and an EC50 value of 0.2 nM.Osocimab may reduce thrombosis through FXI inhibition.Osocimab is often used as an XI factor inhibitor, has an inhibitory effect on thrombin generation, has an anticoagulant effect, and is used in the study of thromboembolic diseases. Thromboembolic Diseases
    • $247
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • INT-767
    T116611000403-03-1
    INT-767 is a potent farnesoid X receptor (FXR)/TGR5 dual agonist that prevents NASH and promotes visceral adipose brown lipogenesis and mitochondrial function for the study of non-alcoholic steatohepatitis.
    • $399
    In Stock
    Size
    QTY
  • Nidufexor
    T78861773489-72-7
    Nidufexor is an agonist for the farnesoid X receptor (FXR).
    • $51
    In Stock
    Size
    QTY
  • BAR502
    TQ02521612191-86-2
    BAR502 is a dual GPBAR1 and FXR agonist (IC50s: 0.4 μM and 2 μM).
    • $107
    In Stock
    Size
    QTY
  • Nelumol A
    TN462877836-86-3
    Nelumol A, and nelumal A show a potency comparable to the endogenous ligand, they may as a valuable potential novel lead compound in the search for FXR agonists.
    • $700
    Backorder
    Size
    QTY
  • LY2562175
    T158061103500-20-4
    LY2562175 is an effective and selective FXR agonist (EC50: 193 nM).
    • $163
    In Stock
    Size
    QTY
  • Tropifexor
    T43791383816-29-2
    Tropifexor (LJN452) is a novel and highly potent agonist of FXR with an EC50 of 0.2 nM.
    • $89
    In Stock
    Size
    QTY
  • Vonafexor
    T84711192171-69-9
    Vonafexor (EYP001) is a farnesoid X receptor (FXR, NR1H4) agonist, with anti-HBV effects
    • $35
    In Stock
    Size
    QTY
  • Guggulsterone
    T557495975-55-6
    Guggulsterone (Guggulsterone E&Z) E&Z is a 3-hydroxy steroid. It has a role as an androgen.
    • $30
    In Stock
    Size
    QTY
  • LY367385
    T15818198419-91-9
    LY367385 is a highly effective and selective mGluR1a antagonist. LY367385 has neuroprotective, anticonvulsant, and antiepileptic effects. Compared with > 100 μM for mGlu5a, LY367385 has an IC50 of 8.8 μM for inhibits of quisqualate-induced phosphoinositide (PI) hydrolysis.
    • $595
    35 days
    Size
    QTY
  • Tauro-Obeticholic acid
    T13092863239-61-6
    Tauro-Obeticholic acid is an active Obeticholic acid metabolite. Obeticholic acid is an orally bioavailable agonist of farnesoid-X receptor (FXR).
    • $119
    In Stock
    Size
    QTY
  • Gly-β-MCA
    T1142666225-78-3
    Gly-β-MCA is an orally bioactive, enteroselective and potent inhibitor of the farnesoid X receptor (FXR), a bile acid, used in the study of obesity and diabetes.
    • $199
    In Stock
    Size
    QTY
  • Cilofexor
    T74361418274-28-8
    Cilofexor inhibits binding of a synthetic peptide, Cilofexor is a farnesoid X receptor (FXR) agonist.
    • $46
    In Stock
    Size
    QTY
  • NDB
    T630421660153-08-1
    NDB is a selective and potent hFXRα antagonist that inhibits GW4064-stimulated FXR/RXR interactions and FXRα target gene expression in primary mouse hepatocytes.NDB is used in the study of diabetes.
    • $99
    In Stock
    Size
    QTY
  • Glyco-Obeticholic acid
    T11428863239-60-5
    Glyco-Obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an agonist of the farnesoid X receptor (FXR).
    • $179
    In Stock
    Size
    QTY
  • DY268
    T315871609564-75-1
    DY268 is a compound based on trisubstituted pyrazolamide without any FXR agonist activity and cytotoxicity and can be used as an effective FXR antagonist (IC50 = 7.5 nM).
    • $34
    In Stock
    Size
    QTY